Autopsy report · NCT00023504

Antibody Production in Immune Disorders

“Slow/Insufficient accrual”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 months before it started.
• Ran for about 19 years 4 months before it stopped.
• 21 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Sponsor type

US National Institutes of Health

Conditions

Primary Immune Deficiency

Interventions

Pneumovax; Rabavert; Prevnar; Tetanus diphtheria toxoid

Participants

21

Sites

1

Countries

United States

Trials that died the same way

• Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery
  “Slow accrual” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.